Lewis Gowers

515 total citations
15 papers, 317 citations indexed

About

Lewis Gowers is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Lewis Gowers has authored 15 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Lewis Gowers's work include Phosphodiesterase function and regulation (8 papers), Phenothiazines and Benzothiazines Synthesis and Activities (5 papers) and Receptor Mechanisms and Signaling (4 papers). Lewis Gowers is often cited by papers focused on Phosphodiesterase function and regulation (8 papers), Phenothiazines and Benzothiazines Synthesis and Activities (5 papers) and Receptor Mechanisms and Signaling (4 papers). Lewis Gowers collaborates with scholars based in United Kingdom and United States. Lewis Gowers's co-authors include Christopher Lowe, David M. Parry, William R. Pitt, George M. Buckley, Verity Sabin, Trevor Morgan, Richard Davenport, Kerry Jenkins, Oliver Rausch and Roland L. Knight and has published in prestigious journals such as Bioorganic & Medicinal Chemistry Letters and ChemInform.

In The Last Decade

Lewis Gowers

15 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lewis Gowers United Kingdom 12 153 125 85 82 67 15 317
Alessia Graziano Italy 14 292 1.9× 210 1.7× 78 0.9× 79 1.0× 44 0.7× 21 467
Elizabeth A. Malloy United States 9 155 1.0× 189 1.5× 51 0.6× 43 0.5× 22 0.3× 10 370
Verity Sabin United Kingdom 14 172 1.1× 162 1.3× 63 0.7× 51 0.6× 46 0.7× 21 372
Geoffrey J. Cutler United Kingdom 9 209 1.4× 95 0.8× 40 0.5× 22 0.3× 87 1.3× 11 335
Daniela Divlianska United States 10 155 1.0× 98 0.8× 72 0.8× 51 0.6× 39 0.6× 12 324
Alexander P. Ducruet United States 9 453 3.0× 146 1.2× 50 0.6× 47 0.6× 29 0.4× 10 545
Christoph Steeneck United States 11 95 0.6× 102 0.8× 30 0.4× 40 0.5× 51 0.8× 15 340
Maxine Norman United Kingdom 8 93 0.6× 77 0.6× 140 1.6× 21 0.3× 35 0.5× 10 301
Gregory R. Luedtke United States 11 158 1.0× 253 2.0× 27 0.3× 48 0.6× 28 0.4× 15 425
Brenda Burton United Kingdom 9 131 0.9× 56 0.4× 102 1.2× 18 0.2× 31 0.5× 10 269

Countries citing papers authored by Lewis Gowers

Since Specialization
Citations

This map shows the geographic impact of Lewis Gowers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lewis Gowers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lewis Gowers more than expected).

Fields of papers citing papers by Lewis Gowers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lewis Gowers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lewis Gowers. The network helps show where Lewis Gowers may publish in the future.

Co-authorship network of co-authors of Lewis Gowers

This figure shows the co-authorship network connecting the top 25 collaborators of Lewis Gowers. A scholar is included among the top collaborators of Lewis Gowers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lewis Gowers. Lewis Gowers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Buckley, George M., Richard Fosbeary, Lewis Gowers, et al.. (2008). IRAK-4 inhibitors. Part III: A series of imidazo[1,2-a]pyridines. Bioorganic & Medicinal Chemistry Letters. 18(12). 3656–3660. 38 indexed citations
2.
Buckley, George M., Lewis Gowers, Alícia P. Higueruelo, et al.. (2008). IRAK-4 inhibitors. Part 1: A series of amides. Bioorganic & Medicinal Chemistry Letters. 18(11). 3211–3214. 29 indexed citations
3.
Buckley, George M., T.A. Ceska, Lewis Gowers, et al.. (2008). IRAK-4 inhibitors. Part II: A structure-based assessment of imidazo[1,2-a]pyridine binding. Bioorganic & Medicinal Chemistry Letters. 18(11). 3291–3295. 38 indexed citations
4.
Davenport, Richard, Richard Fosbeary, Lewis Gowers, et al.. (2008). Synthesis and structure–activity relationship of aminopyrimidine IKK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(12). 3622–3627. 19 indexed citations
5.
Perry, Benjamin, Gavin Bennett, George M. Buckley, et al.. (2008). Optimization of a series of multi-isoform PI3 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(19). 5299–5302. 9 indexed citations
6.
Davenport, Richard, Lewis Gowers, Roland L. Knight, et al.. (2004). A Novel Series of Potent and Selective IKK2 Inhibitors.. ChemInform. 35(18). 1 indexed citations
7.
Davenport, Richard, Lewis Gowers, Roland L. Knight, et al.. (2003). A novel series of potent and selective IKK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(2). 409–412. 43 indexed citations
8.
Buckley, George M., Nicola J. Cooper, Richard Davenport, et al.. (2002). 7-Methoxyfuro[2,3-c]pyridine-4-carboxamides as PDE4 Inhibitors: A Potential Treatment for Asthma. Bioorganic & Medicinal Chemistry Letters. 12(3). 509–512. 17 indexed citations
9.
Billah, Motasim, George M. Buckley, Nicola J. Cooper, et al.. (2002). 8-Methoxyquinolines as PDE4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(12). 1617–1619. 18 indexed citations
10.
Buckley, George M., Nicola Cooper, Hazel J. Dyke, et al.. (2002). 8-Methoxyquinoline-5-carboxamides as PDE4 inhibitors: a potential treatment for asthma. Bioorganic & Medicinal Chemistry Letters. 12(12). 1613–1615. 12 indexed citations
11.
Barnes, Michael R., Nicola Cooper, Richard Davenport, et al.. (2001). Synthesis and structure–activity relationships of guanine analogues as phosphodiesterase 7 (PDE7) inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(8). 1081–1083. 39 indexed citations
12.
Buckley, George M., Nicola Cooper, Hazel J. Dyke, et al.. (2000). 7-Methoxybenzofuran-4-carboxamides as PDE 4 inhibitors: a potential treatment for asthma. Bioorganic & Medicinal Chemistry Letters. 10(18). 2137–2140. 15 indexed citations
13.
Cooper, Nicola, Hazel J. Dyke, Lewis Gowers, et al.. (1998). PDE4 inhibitors: New xanthine analogues. Bioorganic & Medicinal Chemistry Letters. 8(20). 2925–2930. 7 indexed citations
14.
Montana, John G., George M. Buckley, Nicola Cooper, et al.. (1998). Aryl sulfonamides as selective PDE4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 8(19). 2635–2640. 19 indexed citations
15.
Cooper, Nicola, Lewis Gowers, Alan F. Haughan, et al.. (1998). Synthesis and evaluation of a novel series of phosphodiesterase IV inhibitors. A potential treatment for asthma. Bioorganic & Medicinal Chemistry Letters. 8(19). 2629–2634. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026